Cargando…

Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis

Unicystic mucoepidermoid carcinoma (UC-MEC) is a rare MEC variant, and its diagnosis is frequently problematic. This study is aimed at summarizing its clinicopathologic characteristics, treatment, and prognosis and proposing key points to avoid missed diagnosis and misdiagnosis in clinical and patho...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xi, Li, Wei, Feng, Yanrui, Liu, Lingchao, He, Huiying, Li, Binbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489395/
https://www.ncbi.nlm.nih.gov/pubmed/36147445
http://dx.doi.org/10.1155/2022/2676367
_version_ 1784792871041236992
author Wang, Xi
Li, Wei
Feng, Yanrui
Liu, Lingchao
He, Huiying
Li, Binbin
author_facet Wang, Xi
Li, Wei
Feng, Yanrui
Liu, Lingchao
He, Huiying
Li, Binbin
author_sort Wang, Xi
collection PubMed
description Unicystic mucoepidermoid carcinoma (UC-MEC) is a rare MEC variant, and its diagnosis is frequently problematic. This study is aimed at summarizing its clinicopathologic characteristics, treatment, and prognosis and proposing key points to avoid missed diagnosis and misdiagnosis in clinical and pathological conditions. This retrospective study included 30 UC-MEC cases, and the clinical findings were collected from the clinical medical records. Radiographic features, histologic behaviors, MAML2 rearrangement by fluorescence in situ hybridization (FISH), and follow-up data were analyzed. Moreover, glandular odontogenic cyst (GOC) and cytadenoma (CA) were used as controls. In the UC-MEC group, 19 patients were female (63%), and 11 were male (37%). The mean patient age was 39.5 (range, 7–72 years). The affected locations included the jaw (8 maxillary, 3 mandibular) and salivary glands (7 parotid, 11 palates, and 1 floor of the mouth). The chief complaint was swelling; the lesions were all cystic, among which 66.7% were well circumscribed and 33.3% poorly defined. Microscopic examination showed two UC-MEC histologic subtypes. Type A presented as a single cyst with mural thickening (8/30, 27%) lined predominantly by epidermoid cells with interspersed intermediate and mucinous cells, and type B (22/30, 73%) showed infiltrative tumor islands in the cystic wall or the surrounding tissue. FISH analysis suggested that approximately 66.7% of UC-MEC harbored a MAML2 rearrangement. During the median follow-up period of 42 months (range, 6–120 months), all type A patients and 68% of type B patients who underwent complete surgical resection lived without relapse. Seven cases with type B cancer that underwent curettage initially had local recurrence. Clinicians and pathologists hardly recognize UC-MEC owing to its cystic architecture. Specific epidermoid, mucous, and intermediate tumor cells, and MAML2 fusion testing, are essential to avoid potential diagnostic pitfalls. Prompting and completing resection surgery with negative margins would have a favorable prognosis.
format Online
Article
Text
id pubmed-9489395
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94893952022-09-21 Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis Wang, Xi Li, Wei Feng, Yanrui Liu, Lingchao He, Huiying Li, Binbin J Oncol Research Article Unicystic mucoepidermoid carcinoma (UC-MEC) is a rare MEC variant, and its diagnosis is frequently problematic. This study is aimed at summarizing its clinicopathologic characteristics, treatment, and prognosis and proposing key points to avoid missed diagnosis and misdiagnosis in clinical and pathological conditions. This retrospective study included 30 UC-MEC cases, and the clinical findings were collected from the clinical medical records. Radiographic features, histologic behaviors, MAML2 rearrangement by fluorescence in situ hybridization (FISH), and follow-up data were analyzed. Moreover, glandular odontogenic cyst (GOC) and cytadenoma (CA) were used as controls. In the UC-MEC group, 19 patients were female (63%), and 11 were male (37%). The mean patient age was 39.5 (range, 7–72 years). The affected locations included the jaw (8 maxillary, 3 mandibular) and salivary glands (7 parotid, 11 palates, and 1 floor of the mouth). The chief complaint was swelling; the lesions were all cystic, among which 66.7% were well circumscribed and 33.3% poorly defined. Microscopic examination showed two UC-MEC histologic subtypes. Type A presented as a single cyst with mural thickening (8/30, 27%) lined predominantly by epidermoid cells with interspersed intermediate and mucinous cells, and type B (22/30, 73%) showed infiltrative tumor islands in the cystic wall or the surrounding tissue. FISH analysis suggested that approximately 66.7% of UC-MEC harbored a MAML2 rearrangement. During the median follow-up period of 42 months (range, 6–120 months), all type A patients and 68% of type B patients who underwent complete surgical resection lived without relapse. Seven cases with type B cancer that underwent curettage initially had local recurrence. Clinicians and pathologists hardly recognize UC-MEC owing to its cystic architecture. Specific epidermoid, mucous, and intermediate tumor cells, and MAML2 fusion testing, are essential to avoid potential diagnostic pitfalls. Prompting and completing resection surgery with negative margins would have a favorable prognosis. Hindawi 2022-09-13 /pmc/articles/PMC9489395/ /pubmed/36147445 http://dx.doi.org/10.1155/2022/2676367 Text en Copyright © 2022 Xi Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Xi
Li, Wei
Feng, Yanrui
Liu, Lingchao
He, Huiying
Li, Binbin
Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis
title Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis
title_full Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis
title_fullStr Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis
title_full_unstemmed Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis
title_short Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis
title_sort unicystic mucoepidermoid carcinoma: a pitfall for clinical and pathologic diagnosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489395/
https://www.ncbi.nlm.nih.gov/pubmed/36147445
http://dx.doi.org/10.1155/2022/2676367
work_keys_str_mv AT wangxi unicysticmucoepidermoidcarcinomaapitfallforclinicalandpathologicdiagnosis
AT liwei unicysticmucoepidermoidcarcinomaapitfallforclinicalandpathologicdiagnosis
AT fengyanrui unicysticmucoepidermoidcarcinomaapitfallforclinicalandpathologicdiagnosis
AT liulingchao unicysticmucoepidermoidcarcinomaapitfallforclinicalandpathologicdiagnosis
AT hehuiying unicysticmucoepidermoidcarcinomaapitfallforclinicalandpathologicdiagnosis
AT libinbin unicysticmucoepidermoidcarcinomaapitfallforclinicalandpathologicdiagnosis